Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
Clinical trial NCT03210246 · COMPLETED
Trial details
- NCT number
- NCT03210246
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2018-06-21
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.